Beta Bionics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Beta Bionics Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
02/24/2025 | Buy Now | — | Stifel | Mathew Blackman64% | → $25 | Initiates | → Buy | Get Alert |
02/24/2025 | Buy Now | — | Lake Street | Brooks O'Neil36% | → $30 | Initiates | → Buy | Get Alert |
02/24/2025 | Buy Now | — | Piper Sandler | Matt O'Brien51% | → $26 | Initiates | → Overweight | Get Alert |
02/24/2025 | Buy Now | — | Leerink Partners | Mike Kratky66% | → $28 | Initiates | → Outperform | Get Alert |
02/20/2025 | Buy Now | — | Ladenburg Thalmann | Jeff Cohen59% | → $31 | Initiates | → Buy | Get Alert |
02/20/2025 | Buy Now | — | Baird | Jeff Johnson77% | → $20 | Initiates | → Neutral | Get Alert |
The latest price target for Beta Bionics (NASDAQ:BBNX) was reported by Stifel on February 24, 2025. The analyst firm set a price target for $25.00 expecting BBNX to rise to within 12 months (a possible 89.97% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Beta Bionics (NASDAQ:BBNX) was provided by Stifel, and Beta Bionics initiated their buy rating.
There is no last upgrade for Beta Bionics
There is no last downgrade for Beta Bionics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Beta Bionics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Beta Bionics was filed on February 24, 2025 so you should expect the next rating to be made available sometime around February 24, 2026.
While ratings are subjective and will change, the latest Beta Bionics (BBNX) rating was a initiated with a price target of $0.00 to $25.00. The current price Beta Bionics (BBNX) is trading at is $13.16, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.